journal article·2022-05Open access

Cyber‐Physical Watermarking with Inkjet Edible Bioprinting

Hee‐Jae Jeon, Jung Woo Leem, Yuhyun Ji, Sang Mok Park, Jongwoo Park, Kee‐Young Kim, Seong‐Wan Kim, Young L. Kim

Advanced Functional Materials· Volume 32· Issue 18

Abstract

Abstract Counterfeit medicines are a fundamental healthcare problem, threatening patient safety and public health as well as causing economic damage. Online pharmacies and the ongoing pandemic have promoted medicine counterfeiting. However, the existing anticounterfeit methods are limited because of material toxicity, low security, and complicated fabrication. Here a dosage‐level security method is introduced that combines digital watermarking and physical printing at the material level. A set of requirements is designed to ensure the edibility, printability, imperceptibility, and robustness of cyber‐physical watermarking. An inkjet printer using safe food coloring is adapted to print a watermarked image on a recombinant luminescent silk protein taggant to enhance attack resistance. Machine learning of color accuracy recovers unavoidable color distortions during printing and acquisition, allowing robust smartphone readability. An edible watermarked taggant affixed to each individual medicine can offer anticounterfeit and authentication features at the dosage level, empowering every patient to aid in abating illicit medicines.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanomaterials and Printing Technologies · 3D Printing in Biomedical Research · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Weldon School of Biomedical Engineering Purdue University West Lafayette IN 47907 USA

Department of Agricultural Biology National Institute of Agricultural Sciences Rural Development Administration Wanju Jeollabuk‐do 55365 Republic of Korea

Purdue University Center for Cancer Research West Lafayette IN 47907 USA

Regenstrief Center for Healthcare Engineering Purdue University West Lafayette IN 47907 USA

Purdue Quantum Science and Engineering Institute Purdue University West Lafayette IN 47907 USA

Funding

National Institutes of Health

References (100+)

Show source-provided references
1. Buckley G. · 2013
2. 10.4269/ajtmh.14-038910.4269/ajtmh.14-0389 ↗
3. Zaman M. H. · 2018
4. 10.1002/adma.20190548610.1002/adma.201905486 ↗
5. 10.1021/acsnano.0c0728910.1021/acsnano.0c07289 ↗
6. 10.1039/C9QM00607A10.1039/C9QM00607A ↗
7. 10.1039/D1DT00705J10.1039/D1DT00705J ↗
8. World Health Organization Counterfeit medicines https://www.gphf.org/images/downloads/library/who_factsheet275.pdf (accessed: February2006).
9. Science Fake drugs kill more than 250 000 children a year doctors warn https://www.theguardian.com/science/2019/mar/11/fake-drugs-kill-more-than-250000-children-a-year-doctors-warn (accessed: March2019).
10. World Health Organization 1 in 10 medical products in developing countries is substandard or falsified https://www.who.int/news/item/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified (accessed: November2017).
11. 10.1016/S1470-2045(18)30101-310.1016/S1470-2045(18)30101-3 ↗
12. Blackstone E. A. · American Health & Drug Benefits · 2014 · 7 · 216
13. Drug Enforcement Administration (DEA) Counterfeit prescription pills containing fentanyls: a global threat https://www.dea.gov/sites/default/files/docs/Counterfeit%2520Prescription%2520Pills.pdf (accessed: July2016).
14. 10.1371/journal.pone.020318510.1371/journal.pone.0203185 ↗
15. LegitScript The Internet Pharmacy Market in 2016https://safemedsonline.org/wp-content/uploads/2016/01/The-Internet-Pharmacy-Market-in-2016.pdf (accessed: January2016).
16. Sklamberg H. · 2014
17. AI can help find illegal opioid sellers online. And wildlife traffickers. And counterfeits https://www.vox.com/recode/2020/1/21/21060680/opioids-artificial-intelligence-illegal-online-pharmacies (accessed: January2020).
18. LegitScript The criminal of COVID‐19 https://www.legitscript.com/dl/covid19-special-report/ (accessed: September2021).
19. 10.4269/ajtmh.20-090310.4269/ajtmh.20-0903 ↗
20. 10.1016/S2214-109X(20)30136-410.1016/S2214-109X(20)30136-4 ↗
21. Food and Drug Administration (FDA) Drug Supply Chain Security Act Resources for State Officials https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/drug-supply-chain-security-act-resources-state-officials (accessed: August2021).
22. European Medicines Agency (EMA) Falsified medicines: Overview https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/falsified-medicines-overview (accessed: October2021).
23. Shanley A. · Pharm. Technol. · 2018 · 42 · 56
24. 10.1080/14740338.2017.131322710.1080/14740338.2017.1313227 ↗
25. 10.1371/journal.pone.009060110.1371/journal.pone.0090601 ↗
26. 10.1310/hpj5106-49310.1310/hpj5106-493 ↗
27. 10.1016/j.ijpharm.2017.11.05210.1016/j.ijpharm.2017.11.052 ↗
28. 10.1016/j.msec.2016.03.00410.1016/j.msec.2016.03.004 ↗
29. 10.1109/ICIT.2019.875496610.1109/ICIT.2019.8754966 ↗
30. 10.1002/adma.20130067510.1002/adma.201300675 ↗
31. 10.1126/sciadv.170138410.1126/sciadv.1701384 ↗
32. 10.1002/adma.20140124610.1002/adma.201401246 ↗
33. 10.1038/ncomms986710.1038/ncomms9867 ↗
34. 10.1126/sciadv.aav579010.1126/sciadv.aav5790 ↗
35. 10.1038/srep0206510.1038/srep02065 ↗
36. 10.1126/sciadv.abg398910.1126/sciadv.abg3989 ↗
37. 10.1126/sciadv.abg036310.1126/sciadv.abg0363 ↗
38. 10.1002/978111802367910.1002/9781118023679 ↗
39. 10.1038/s41467-019-14066-510.1038/s41467-019-14066-5 ↗
40. c)F.Thomas Securing each dose: reducing falsification risk with dosage level authentication https://www.pharmtech.com/view/securing-each-dose (accessed: April2021).
41. 10.1126/sciadv.170007110.1126/sciadv.1700071 ↗
42. 10.1021/acsomega.0c0520710.1021/acsomega.0c05207 ↗
43. 10.1002/smll.20170180410.1002/smll.201701804 ↗
44. 10.1038/nmat474710.1038/nmat4747 ↗
45. 10.1002/adfm.20150398910.1002/adfm.201503989 ↗
46. 10.1021/acsnano.0c0897410.1021/acsnano.0c08974 ↗
47. 10.1179/204777312X1341924593948510.1179/204777312X13419245939485 ↗
48. 10.1016/j.ijpharm.2020.11986610.1016/j.ijpharm.2020.119866 ↗
49. 10.1002/adfm.20210210810.1002/adfm.202102108 ↗
50. 10.1007/s00204-013-1128-z10.1007/s00204-013-1128-z ↗
51. Younes M. · EFSA J. · 2018 · 16 · 5238
52. 10.1016/j.tifs.2020.05.02510.1016/j.tifs.2020.05.025 ↗
53. 10.3390/polym1310159210.3390/polym13101592 ↗
54. 10.1111/bcpt.1278110.1111/bcpt.12781 ↗
55. 10.1080/15287394.2019.159805310.1080/15287394.2019.1598053 ↗
56. 10.1016/j.envpol.2021.11802110.1016/j.envpol.2021.118021 ↗
57. 10.1016/j.cosrev.2017.11.00310.1016/j.cosrev.2017.11.003 ↗
58. 10.1007/s12652-019-01500-110.1007/s12652-019-01500-1 ↗
59. 10.1109/TITB.2006.87565510.1109/TITB.2006.875655 ↗
60. Lin C.‐Y. · 2001
61. Cox I. J. · 2002
62. 10.1109/ACCESS.2020.300768910.1109/ACCESS.2020.3007689 ↗
63. 10.1016/j.image.2020.11612410.1016/j.image.2020.116124 ↗
64. Lin C.‐Y. · 1999
65. Pramila A. · 2008 · 60
66. Pramila A. · 2008
67. 10.1002/app.4850510.1002/app.48505 ↗
68. 10.1557/s43579-020-00003-x10.1557/s43579-020-00003-x ↗
69. 10.1021/acssuschemeng.0c0336510.1021/acssuschemeng.0c03365 ↗
70. 10.1038/srep2526310.1038/srep25263 ↗
71. 10.7744/kjoas.2016001310.7744/kjoas.20160013 ↗
72. 10.1093/jn/133.6.190910.1093/jn/133.6.1909 ↗
73. 10.1146/annurev-bioeng-082719-03274710.1146/annurev-bioeng-082719-032747 ↗
74. 10.1038/7197810.1038/71978 ↗
75. 10.1073/pnas.130598711010.1073/pnas.1305987110 ↗
76. 10.1002/adbi.20200004010.1002/adbi.202000040 ↗
77. 10.1039/C6MH00423G10.1039/C6MH00423G ↗
78. 10.1016/j.biomaterials.2015.08.02510.1016/j.biomaterials.2015.08.025 ↗
79. 10.1002/advs.20170086310.1002/advs.201700863 ↗
80. 10.1074/jbc.272.45.2854510.1074/jbc.272.45.28545 ↗
81. 10.1016/S0006-3495(97)78307-310.1016/S0006-3495(97)78307-3 ↗
82. Berg J. · 2002
83. 10.1002/rcm.346710.1002/rcm.3467 ↗
84. 10.1016/B978-0-12-091302-2.50099-210.1016/B978-0-12-091302-2.50099-2 ↗
85. 10.1016/j.ab.2005.02.02210.1016/j.ab.2005.02.022 ↗
86. 10.1002/adem.20210073310.1002/adem.202100733 ↗
87. 10.1007/s11947-016-1692-310.1007/s11947-016-1692-3 ↗
88. 10.1021/la010791y10.1021/la010791y ↗
89. 10.1039/C6RA28460D10.1039/C6RA28460D ↗
90. 10.3390/info1102011010.3390/info11020110 ↗
91. 10.1364/OE.42006910.1364/OE.420069 ↗
92. 10.1364/OE.42598810.1364/OE.425988 ↗
93. 10.1364/JOSAA.33.00058910.1364/JOSAA.33.000589 ↗
94. Ibraheem N. A. · ARPN Journal of Science and Technology · 2012 · 2 · 265
95. 10.1109/TIP.2015.240533610.1109/TIP.2015.2405336 ↗
96. 10.1109/5.98240610.1109/5.982406 ↗
97. Cox I. J. · 1997
98. Asmara R. A. · International Journal of Advanced Computer Science and Applications · 2017 · 8 · 245
99. Singh Y. S. · Int. J. Eng. Res. · 2013 · 2 · 193
100. 10.1007/s11042-020-09716-610.1007/s11042-020-09716-6 ↗